Patil Neena M sold 1,200 Jazz Pharmaceuticals shares at $240.94 each on Sept. 10, leaving her with 47,671 shares. The sale represented about 2.5% of her prior holding, giving investors the disclosed size of the transaction and the executive’s remaining position.
Key Highlights
- Jazz Pharmaceuticals identifies Patil Neena M as its EVP and chief legal officer.
- SEC transaction code S classifies the activity as an open-market sale.
- The transaction represented about 2.5% of Patil Neena M’s prior shares holding.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) executive Patil Neena M sold 1,200 shares at $240.94 per share on 10 September 2026, leaving her with 47,671 shares. The transaction represented about 2.5% of her prior shares holding.
$240.94 Per-Share Sale Recorded
Patil Neena M’s transaction involved 1,200 Jazz Pharmaceuticals plc shares at $240.94 per share. The transaction date was 10 September 2026. The reported price applies to each share involved in the transaction.
Post-Transaction Holding Stands at 47,671 Shares
Following the transaction, her reported ownership of Jazz Pharmaceuticals plc stood at 47,671 shares. The percentage uses the prior holding as its reference, while 47,671 shares represents the stated position after the transaction. The disclosed figures show both the transaction’s proportion and the remaining ownership balance.
FAQs
Q: What happened in the Jazz Pharmaceuticals insider sale?
A: Patil Neena M sold 1,200 Jazz Pharmaceuticals plc shares at $240.94 per share on 10 September 2026. After the sale, she held 47,671 shares, and the transaction represented about 2.5% of her prior shareholding.
Q: How many Jazz Pharmaceuticals shares did Patil Neena M retain?
A: Patil Neena M held 47,671 Jazz Pharmaceuticals plc shares after the sale. The transaction’s 2.5% figure was calculated against her prior shares holding.
Q: What did Patil Neena M sell?
A: Patil Neena M sold 1,200 shares of Jazz Pharmaceuticals plc. The sale occurred at $240.94 per share on 10 September 2026.
Q: What position does Patil Neena M hold at Jazz Pharmaceuticals?
A: Patil Neena M is Jazz Pharmaceuticals plc’s EVP and chief legal officer. Her reported transaction involved shares of the company on 10 September 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.